Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Pneumonia, Pneumococcal 1Pneumococcal Infections 1Multiple Myeloma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Febrile Neutropenia 1

Interventions

Meropenem 6Ceftazidime 5Vancomycin 4Ciprofloxacin 3Cefepime 3Teicoplanin 2Levofloxacin 2Amikacin 2ceftolozane, tazobactam drug combination 1Vaccination 1Tazobactam 1Simvastatin 1Pneumococcal Vaccines 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Ofloxacin 1Micafungin 1Metronidazole 1Injections 1Filgrastim 1Cilastatin, Imipenem Drug Combination 1Anti-Bacterial Agents 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Febrile Neutropenia × Pneumococcal Vaccines × Clear all
NCT03619252 2022-08-31

Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents

Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology

Phase 4 Completed
36 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Pneumococcal Infections, Pneumonia, Pneumococcal, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡